These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12647307)

  • 1. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
    Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
    J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
    Sahara T; Itoh K; Debari K; Sasaki T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
    Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK
    Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 Protein.
    Zhu S; Rea SL; Cheng T; Feng HT; Walsh JP; Ratajczak T; Tickner J; Pavlos N; Xu HZ; Xu J
    J Cell Biochem; 2016 Jun; 117(6):1464-70. PubMed ID: 27043248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
    J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes.
    Matsumoto N; Nakanishi-Matsui M
    Biochem Biophys Res Commun; 2019 Mar; 510(3):421-426. PubMed ID: 30717974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo.
    Sundquist KT; Marks SC
    J Bone Miner Res; 1994 Oct; 9(10):1575-82. PubMed ID: 7817803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
    Liu S; Zhu W; Li S; Ma J; Zhang H; Li Z; Zhang L; Zhang B; Li Z; Liang X; Shi W
    Int J Mol Med; 2016 Feb; 37(2):284-92. PubMed ID: 26647715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of osteoclast vacuolar H(+)-ATPase.
    Farina C; Gagliardi S
    Curr Pharm Des; 2002; 8(23):2033-48. PubMed ID: 12171517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
    Nyman JK; Väänänen HK
    Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
    Lees RL; Sabharwal VK; Heersche JN
    Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.
    Hiasa M; Okui T; Allette YM; Ripsch MS; Sun-Wada GH; Wakabayashi H; Roodman GD; White FA; Yoneda T
    Cancer Res; 2017 Mar; 77(6):1283-1295. PubMed ID: 28254863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [V-ATPase inhibitor baflomycine A1 inhibits bone resorption by osteoclast-like cells].
    Zhao N; Yu S
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):436-9. PubMed ID: 11869558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
    Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
    Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
    Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
    Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclasts play a part in pain due to the inflammation adjacent to bone.
    Nagae M; Hiraga T; Wakabayashi H; Wang L; Iwata K; Yoneda T
    Bone; 2006 Nov; 39(5):1107-1115. PubMed ID: 16769263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
    Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
    J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.